PolyProx Therapeutics - PolyProx - focused on the discovery and development of a new class of drugs to treat cancer and neurodegenerative diseases

Welcome to PolyProx Therapeutics

PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin® molecules, to treat cancer and neurodegenerative diseases. Polyproxin® molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.

About Us

Find out more about our current focus to develop Polyproxin® drug candidates for use in the treatment of cancers.

News & Events

Catch up on the latest news, developments and press releases relating to PolyProx Therapeutics.

Team

From the global biotechnology industry, to leading academic research and pharmaceutical discovery, our team shares a vast range of knowledge and experience.